ST
Sialia Therapeutics, Inc.
SEC filingBiotechnology · Irvine, CA
Amount raised$1.5Msold at filing
Total offering$1.5M
Investors in the raise1count reported to the SEC
FiledSep 29, 2026first sale Sep 2, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Litain YehExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.